Original Article

Concentrations of B Vitamins and Homocysteine in Children with Sickle Cell Anemia

Authors: Jodi B. Segal, MD, MPH, Edgar R. Miller, III, MD, PHD, Nga Hong Brereton, MS, RD, Linda M.S. Resar, MD

Abstract

Background: Elevated concentration of serum homocysteine contributes to thrombosis, a frequent event in patients with sickle cell anemia. We aimed to test whether children with sickle cell anemia have elevated concentrations of serum homocysteine with diminished levels of folate or B vitamins from accelerated blood cell turnover.


Methods: We conducted a case-control study of children with homozygous sickle cell anemia (n = 17) and unaffected children (n = 11). We measured serum and red blood cell folate, vitamin B6, vitamin B12, and homocysteine concentrations, and assessed micronutrient intake.


Results: Children with sickle cell anemia had concentrations of homocysteine slightly higher than those of unaffected children. They had lower vitamin B6 concentrations and comparable concentrations of folate and vitamin B12. Homocysteine concentration was inversely related to vitamin B12 concentration and was not independently associated with levels of vitamin B6or folate.


Conclusion: Despite comparable intake, children with sickle cell anemia had lower concentrations of vitamin B6 than unaffected children. Larger studies are needed to determine if chronically low serum vitamin B6 concentration contributes to hyperhomocysteinemia in this population.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Wood DH. Cerebrovascular complications of sickle cell anemia. Stroke 1978; 9: 73–75.
 
2. Balkaran B, Char G, Morris JS, et al. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr 1992; 120: 360–366.
 
3. Powars D, Wilson B, Imbus C, et al. The natural history of stroke in sickle cell disease. Am J Med 1978; 65: 461–471.
 
4. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell diseases: Rates and risk factors. Blood 1998; 91: 288–294.
 
5. Francis RB Jr. Elevated fibrin d -dimer fragment in sickle cell anemia: Evidence for activation of coagulation during the steady state as well as in painful crisis. Haemostasis 1989; 19: 105–111.
 
6. Perry IJ, Refsum H, Morris RW, et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995; 346: 1395–1398.
 
7. Petri M, Roubenoff R, Dallal GE, et al. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 1996; 348: 1120–1124.
 
8. Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995; 332: 286–291.
 
9. van den Berg M, Stehouwer CD, Bierdrager E, et al. Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease. Arterioscler Thromb Vasc Biol 1996; 16: 165–171.
 
10. Nygard O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine concentrations and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230–236.
 
11. Malinow MR, Nieto FJ, Szklo M, et al. Carotid artery intimal-medial wall thickening and plasma homocysteine in asymptomatic adults: The Atherosclerosis Risk in Communities Study. Circulation 1993; 87: 1107–1113.
 
12. Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049–1057.
 
13. Robinson K, Mayer EL, Miller DP, et al. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation 1995; 92: 2825–2830.
 
14. Kang SS, Wong PW, Norusis M. Homocysteinemia due to folate deficiency. Metabolism 1987; 36: 458–462.
 
15. Mansoor MA, Kristensen O, Hervig T, et al. Plasma total homocysteine response to oral doses of folic acid and pyridoxine hydrochloride (vitamin B6) in healthy individuals: Oral doses of vitamin B6reduce concentrations of serum folate. Scand J Clin Lab Invest 1999; 59: 139–146.
 
16. Vermeulen EG, Stehouwer CD, Twisk JW, et al. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: A randomized, placebo-controlled trial. Lancet 2000; 355: 517–522.
 
17. McKinley MC. Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: An independent risk factor for vascular disease. Proc Nutr Soc 2000; 59: 221–237.
 
18. Selhub J, Jacques PF, Wilson PW, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270: 2693–2698.
 
19. Schrijver J, Speek AJ, Schreurs WH. Semi-automated fluorometric determination of pyridoxal-5′-phosphate (vitamin B6) in whole blood by high-performance liquid chromatography (HPLC). Int J Vitam Nutr Res 1981; 51: 216–222.
 
20. Ueland PM, Refsum H, Stabler SP, et al. Total homocysteine in plasma or serum: Methods and clinical applications. Clin Chem 1993; 39: 1764–1779.
 
21. Dunn RT, Foster LB. Radioassay of serum folate. Clin Chem 1973; 19: 1101–1105.
 
22. Bingham SA, Gill C, Welch A, et al. Comparison of dietary assessment methods in nutritional epidemiology: Weighed records vs. 24-hr recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr 1994; 72: 619–643.PubMed | CrossRef
 
23. Buzzard IM, Faucett CL, Jeffery RW, et al. Monitoring dietary change in a low-fat diet intervention study: Advantages of using 24-hour dietary recalls vs food records. J Am Diet Assoc 1996; 96: 574–579.
 
24. Kuehneman T, Stanek K, Eskridge K, et al. Comparability of four methods for estimating portion sizes during a food frequency interview with caregivers of young children. J Am Diet Assoc 1994; 94: 548–551.
 
25. Haraldsdottir J, Hermansen B. Repeated 24-hr recalls with young schoolchildren: A feasible alternative to dietary history from parents? Eur J Clin Nutr 1995; 49: 729–739.
 
26. Recommended Dietary Allowances. Washington, DC, National Academy Press, 1989, ed 10, pp 284–285.
 
27. Osganian SK, Stampfer MJ, Spiegelman D, et al. Distribution of and factors associated with serum homocysteine concentrations in children: Child and Adolescent Trial for Cardiovascular Health. JAMA 1999; 281: 1189–1196.
 
28. van der Dijs FP, Schnog JJ, Brouwer DA, et al. Elevated homocysteine concentrations indicate suboptimal folate status in pediatric sickle cell patients. Am J Hematol 1998; 59: 192–198.
 
29. Balasa VV, Gruppo RA, Gartside PS, et al. Correlation of the C677T MTHFR genotype with homocysteine levels in children with sickle cell disease. J Pediatr Hematol Oncol 1999; 21: 397–400.
 
30. Balasa VV, Gruppo RA, Glueck CJ, et al. The relationship of mutations in the MTHFR, prothrombin, and PAI-l genes to plasma concentrations of homocysteine, prothrombin, and PAI-l in children and adults. Thromb Haemost 1999; 81: 739–744.
 
31. Houston PE, Rana S, Sekhsaria S, et al. Homocysteine in sickle cell disease: Relationship to stroke. Am J Med 1997; 103: 192–196.
 
32. Rodriguez-Cortes HM, Griener JC, Hyland K, et al. Plasma homocysteine concentrations and folate status in children with sickle cell anemia. J Pediatr Hematol Oncol 1999; 21: 219–223.
 
33. Lowenthal EA, Mayo MS, Cornwell PE, et al. Homocysteine elevation in sickle cell disease. J Am Coll Nutr 2000; 19: 608–612.PubMed | CrossRef
 
34. Liu YK. Folate deficiency in children with sickle cell anemia. Am J Dis Child 1974; 127: 389–393.
 
35. Liu YK. Folic acid deficiency in sickle cell anemia. Scand J Haematol 1975; 14: 71–79.
 
36. Muskiet FA, van der Dijs FP, Fokkema MR, et al. Erythrocyte folate does not accurately reflect folate status in sickle cell disease. Clin Chem 2000; 46: 2015–2016.
 
37. Kennedy TS, Fung EB, Kawchak DA, et al. Red blood cell folate and serum vitamin B12 status in children with sickle cell disease. J Pediatr Hematol Oncol 2001; 23: 165–169.
 
38. Appel LJ, Miller ER III, Jee SH, et al. Effect of dietary patterns on serum homocysteine: Results of a randomized, controlled feeding study. Circulation 2000; 102: 852–857.
 
39. Flores L, Pais R, Buchanan I, et al. Pyridoxal 5′-phosphate concentrations in children with sickle cell disease. Am J Pediatr Hematol Oncol 1988; 10: 236–240.
 
40. Balasa VV, Kalinyak KA, Gruppo RA. Homocysteine and vitamin cofactor levels in patients with sickle cell disease. Thromb Haemost 2001; 86 (1 Suppl): Abstract OC2515.
 
41. Natta CL, Reynolds RD. Apparent vitamin B6 deficiency in sickle cell anemia. Am J Clin Nutr 1984; 40: 235–239.
 
42. Gregory JF III. Bioavailability of vitamin B6. Eur J Clin Nutr 1997; 51 (Suppl 1): S43–S48.